Insider · CIK 0001613842
Luca Benatti
Files at ICPT (INTERCEPT PHARMACEUTICALS, INC.), QNCX (Quince Therapeutics, Inc.). First filing Dec 29, 2025, latest Dec 29, 2025.
In brief
Luca Benatti files SEC Form 4 as director at QNCX (Quince Therapeutics, Inc.), and also at ICPT (INTERCEPT PHARMACEUTICALS, INC.). Since Dec 29, 2025, Luca Benatti has reported 0 open-market buys worth $0 and 1 open-market sell worth $174k, the latest filed on Dec 29, 2025.
A track record needs three past buys with six months of prices behind them; Luca Benatti has 0, so none is measured yet.
The newest scored trade: sold $174k of QNCX on Dec 26, 2025, filed Dec 29, 2025, scored 46 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $174k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
QNCX: Quince Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | QNCXsell Quince Therapeutics, Inc. | $174k 50,000 shares | -56% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 29, 2025 | QNCX QUINCE THERAPEUTICS INC | 50,000 0.09% of outstanding | $173k | Dec 26, 2025 | none |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 23, 2024 | QNCX Quince Therapeutics, Inc. | JOther Common Stock | +8,918 | - | - | 89,179 | Dec 29, 2025 |
| Dec 26, 2025 | QNCX Quince Therapeutics, Inc. | SOpen-market sale Common Stock | -50,000 | $3.47 | $174k | 39,179 | Dec 29, 2025 |
| Jun 4, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +27,000 | $0.00 | $0 | 27,000 | Jun 6, 2025 |
| Jun 5, 2024 | QNCX Quince Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +27,000 | $0.00 | $0 | 27,000 | Jun 7, 2024 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | UTender of shares Common Stock | -25,487 | $19.00 | $484k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -8,111 | $19.00 | $154k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -12,089 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -12,790 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -12,547 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -551 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -1,750 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -1,598 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -2,036 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -2,748 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -2,174 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -2,966 | - | - | 0 | Nov 13, 2023 |
| Oct 23, 2023 | QNCX Quince Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +54,000 | $0.00 | $0 | 54,000 | Oct 24, 2023 |
Questions about Luca Benatti
Answered from the filings on this page, as of the latest one.
Is Luca Benatti buying or selling?
In the last 12 months Luca Benatti reported 0 open-market buys worth $0 and 1 open-market sell worth $174k on SEC Form 4; the latest was sold $174k of QNCX on Dec 26, 2025. Grants, option exercises and tax withholding are not counted.
How did Luca Benatti's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Luca Benatti has 0.
Where does Luca Benatti file Form 4?
Luca Benatti has filed Form 4 at QNCX (Quince Therapeutics, Inc.); ICPT (INTERCEPT PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.